ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 218 filers reported holding ALKERMES PLC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $267,552 | -5.7% | 9,552 | +5.4% | 0.01% | 0.0% |
Q2 2023 | $283,578 | +14.2% | 9,060 | +2.8% | 0.01% | +7.7% |
Q1 2023 | $248,354 | -7.6% | 8,810 | -14.3% | 0.01% | +8.3% |
Q4 2022 | $268,643 | -8.2% | 10,281 | +4.6% | 0.01% | -7.7% |
Q2 2022 | $292,776 | +13.2% | 9,828 | 0.0% | 0.01% | +44.4% |
Q1 2022 | $258,575 | -73.6% | 9,828 | -76.7% | 0.01% | -30.8% |
Q4 2021 | $980,107 | -24.6% | 42,137 | 0.0% | 0.01% | -31.6% |
Q3 2021 | $1,299,505 | +20.4% | 42,137 | -4.2% | 0.02% | +26.7% |
Q2 2021 | $1,078,880 | +1707.1% | 44,000 | +1276.7% | 0.02% | +1400.0% |
Q1 2021 | $59,701 | -2.6% | 3,196 | +4.0% | 0.00% | 0.0% |
Q4 2020 | $61,286 | -1.7% | 3,072 | -4.4% | 0.00% | 0.0% |
Q2 2020 | $62,348 | -15.2% | 3,213 | -14.7% | 0.00% | 0.0% |
Q3 2019 | $73,514 | -71.2% | 3,768 | -66.8% | 0.00% | -75.0% |
Q2 2019 | $255,536 | -39.6% | 11,337 | -2.3% | 0.00% | -50.0% |
Q1 2019 | $423,248 | +21.1% | 11,599 | -2.0% | 0.01% | +14.3% |
Q4 2018 | $349,428 | -99.9% | 11,841 | -2.3% | 0.01% | -12.5% |
Q2 2018 | $498,695,000 | -24.4% | 12,116 | +6.4% | 0.01% | -11.1% |
Q1 2018 | $659,701,000 | +105791.0% | 11,382 | +0.0% | 0.01% | +12.5% |
Q4 2017 | $623,000 | +6.7% | 11,379 | -0.9% | 0.01% | +100.0% |
Q3 2017 | $584,000 | -7.6% | 11,486 | +5.4% | 0.00% | 0.0% |
Q2 2017 | $632,000 | +4.6% | 10,900 | +5.5% | 0.00% | 0.0% |
Q1 2017 | $604,000 | +5.2% | 10,329 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $574,000 | +13.0% | 10,329 | -4.3% | 0.00% | 0.0% |
Q3 2016 | $508,000 | +3.9% | 10,794 | -4.6% | 0.00% | 0.0% |
Q2 2016 | $489,000 | +4.7% | 11,312 | +23.4% | 0.00% | +33.3% |
Q2 2014 | $467,000 | +3.1% | 9,164 | -1.6% | 0.00% | 0.0% |
Q1 2014 | $453,000 | +28.0% | 9,310 | +7.1% | 0.00% | +50.0% |
Q4 2013 | $354,000 | +21.2% | 8,696 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $292,000 | +15.4% | 8,696 | -1.3% | 0.00% | 0.0% |
Q2 2013 | $253,000 | – | 8,812 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
13D Management LLC | 415,055 | $9,268,000 | 4.85% |
Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |